Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

Respilean works in a plethora of ways to help improve respiratory function. That is to say, the choice of ingredients ...

Smoke from a fire can have a dangerous impact on your physical and mental health, even from thousands of miles away.

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... in combination with inhaled corticosteroids (ICS), so ...

Note: The chronological list does not include December ... Ohtuvayre (ensifentrine) for COPD: Approved June 26, the inhaled medication is the first new type of maintenance COPD drug in over ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

They provided evidence to guide treatment decisions for COPD patients. Study: Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease ...